1TN FUND, L.C. – Trademark Portfolio

Entity Type: 22

1TN FUND, L.C. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 7 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include N, TRUENORTH, TRUE NORTH, CLINICAL COMPASS, and PROTECT AND MAXIMIZE. The owner is based in CEDAR RAPIDS, IA.

500 1ST ST SE

CEDAR RAPIDS, IA 52401

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

1TN FUND, L.C.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (7 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does 1TN FUND, L.C. have?

1TN FUND, L.C. has 7 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned.

What trademark classes does 1TN FUND, L.C. file in?

1TN FUND, L.C. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 35 (Advertising & Business). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are 1TN FUND, L.C.'s most well-known trademarks?

1TN FUND, L.C.'s registered trademark portfolio includes well-known marks such as N, TRUENORTH, TRUE NORTH, CLINICAL COMPASS, and PROTECT AND MAXIMIZE. These are among 6 currently registered trademarks in the portfolio.

What is 1TN FUND, L.C.'s trademark registration success rate?

1TN FUND, L.C. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.